Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
Clinical trial NCT00144222 · COMPLETED
Trial details
- NCT number
- NCT00144222
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Primary completion
- 2005-08-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.